Adage Capital Partners’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.9M Hold
1,400,000
0.03% 518
2025
Q1
$15.8M Hold
1,400,000
0.03% 473
2024
Q4
$14.7M Hold
1,400,000
0.03% 511
2024
Q3
$14.6M Hold
1,400,000
0.03% 533
2024
Q2
$14.3M Hold
1,400,000
0.03% 523
2024
Q1
$14.6M Buy
+1,400,000
New +$14.6M 0.03% 531